10-K Filing

LifeMD, Inc. CIK: 948320 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001213900-16-011978`
Period End Date	20151231
Filing Date	20160330
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	immd-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 47 Income Statement 40 Cash Flow Statement 48 Stockholders Equity 18

Balance Sheet 47 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.01M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.73M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$155.06K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	32.01M	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$14.97K	USD	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$154.44K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.73M	shares	Point-in-time
Inventory	`InventoryNet`	$41.01K	USD	Point-in-time
Inventory	`InventoryNet`	$61.05K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$448.47K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$131.47K	USD	Point-in-time
Furnishings and equipment	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Furnishings and equipment	`PropertyPlantAndEquipmentNet`	$43.75K	USD	Point-in-time
Total Assets	`Assets`	$175.22K	USD	Point-in-time
Total Assets	`Assets`	$448.47K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$167.48K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$274.32K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$40.20K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$100.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$27.20K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$301.52K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$267.48K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$13.20K	USD	Point-in-time
Total Liabilities	`Liabilities`	$314.72K	USD	Point-in-time
Total Liabilities	`Liabilities`	$267.48K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 32,010,375 and 30,729,973 shares issued and outstanding in 2015 and 2014, respectively	`CommonStockValue`	$320.10K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 32,010,375 and 30,729,973 shares issued and outstanding in 2015 and 2014, respectively	`CommonStockValue`	$307.30K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$8.37M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$8.08M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-8.59M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-8.52M	USD	Point-in-time
Total Immudyne, Inc. Stockholders' Equity (Deficit)	`StockholdersEquity`	$100.08K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' Equity (Deficit)	`StockholdersEquity`	$-139.50K	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$80.91K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$195.49K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-139.50K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$175.22K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$448.47K	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Sales	`Revenues`	$1.22M	USD	Annual
Sales	`Revenues`	$714.16K	USD	Annual
Cost of sales	`CostOfRevenue`	$247.77K	USD	Annual
Cost of sales	`CostOfRevenue`	$172.85K	USD	Annual
Gross Profit	`GrossProfit`	$971.09K	USD	Annual
Gross Profit	`GrossProfit`	$541.31K	USD	Annual
Compensation and related expenses	`CompensationAndRelatedExpenses`	$532.42K	USD	Annual
Compensation and related expenses	`CompensationAndRelatedExpenses`	$558.97K	USD	Annual
Professional fees	`ProfessionalFees`	$139.55K	USD	Annual
Professional fees	`ProfessionalFees`	$114.89K	USD	Annual
Marketing expenses	`MarketingExpense`	$57.25K	USD	Annual
Marketing expenses	`MarketingExpense`	$230.66K	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	$23.93K	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	-	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$331.41K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$316.42K	USD	Annual
Operating (Loss)	`OperatingIncomeLoss`	$-530.88K	USD	Annual
Operating (Loss)	`OperatingIncomeLoss`	$-262.22K	USD	Annual
Gain on sale of Adiuvo Investment S.A. stock	`GainOnSaleOfInvestments`	-	USD	Annual
Gain on sale of Adiuvo Investment S.A. stock	`GainOnSaleOfInvestments`	$127.26K	USD	Annual
License Fee	`LicenseCosts`	-	USD	Annual
License Fee	`LicenseCosts`	$50.00K	USD	Annual
Other income	`OtherIncome`	$7.88K	USD	Annual
Other income	`OtherIncome`	-	USD	Annual
Interest (expense)	`InterestExpense`	$4.68K	USD	Annual
Interest (expense)	`InterestExpense`	$37.48K	USD	Annual
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-477.69K	USD	Annual
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-172.43K	USD	Annual
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-13.20K	USD	Annual
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-17.20K	USD	Annual
Net (Loss)	`ProfitLoss`	$-159.23K	USD	Annual
Net (Loss)	`ProfitLoss`	$-460.49K	USD	Annual
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-97.24K	USD	Annual
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net (Loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-460.49K	USD	Annual
Net (Loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-61.99K	USD	Annual
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	Annual
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.81M	shares	Annual
Weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.37M	shares	Annual

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net (Loss)	`ProfitLoss`	$-159.23K	USD	Annual
Net (Loss)	`ProfitLoss`	$-460.49K	USD	Annual
Depreciation	`Depreciation`	$56.98K	USD	Annual
Depreciation	`Depreciation`	$43.75K	USD	Annual
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-13.20K	USD	Annual
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-17.20K	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$45.00K	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$77.30K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$65.00K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$80.50K	USD	Annual
Gain on sale of Adiuvo Investment S.A. stock	`GainLossOnSaleOfInvestments`	-	USD	Annual
Gain on sale of Adiuvo Investment S.A. stock	`GainLossOnSaleOfInvestments`	$127.26K	USD	Annual
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$139.47K	USD	Annual
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-62.51K	USD	Annual
Legal settlement proceeds receivable	`IncreaseDecreaseInLegalSettlement`	$-132.00K	USD	Annual
Legal settlement proceeds receivable	`IncreaseDecreaseInLegalSettlement`	-	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-45.19K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$20.04K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-21.97K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$88.96K	USD	Annual
Net Cash (Used) provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$33.44K	USD	Annual
Net Cash (Used) provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-295.12K	USD	Annual
Proceeds from sale of Adiuvo Investment S.A. stock	`PaymentsForProceedsFromInvestments`	-	USD	Annual
Proceeds from sale of Adiuvo Investment S.A. stock	`PaymentsForProceedsFromInvestments`	$-127.26K	USD	Annual
Deposit payable	`PaymentsForProceedsFromDeposit`	-	USD	Annual
Deposit payable	`PaymentsForProceedsFromDeposit`	$100.00K	USD	Annual
Increase in notes payable	`IncreaseDecreaseInNotesPayableCurrent`	$67.00K	USD	Annual
Increase in notes payable	`IncreaseDecreaseInNotesPayableCurrent`	$305.00K	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$147.00K	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$80.00K	USD	Annual
Purchase of Company stock	`PaymentsOfDividendsCommonStock`	$10.80K	USD	Annual
Purchase of Company stock	`PaymentsOfDividendsCommonStock`	-	USD	Annual
Investment in subsidiary by noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	Annual
Investment in subsidiary by noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$178.15K	USD	Annual
Net Cash Provided (Used) by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-113.00K	USD	Annual
Net Cash Provided (Used) by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$325.35K	USD	Annual
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$157.49K	USD	Annual
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-79.56K	USD	Annual
Cash at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Cash at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$155.06K	USD	Point-in-time
Cash at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Cash at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at end of the year	`CashAndCashEquivalentsAtCarryingValue`	$155.06K	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$4.68K	USD	Annual
Cash paid for interest	`InterestPaid`	$28.98K	USD	Annual
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	-	USD	Annual
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	$170.07K	USD	Annual

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$195.49K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-139.50K	USD	Point-in-time
Amortization of stock options	`AdjustmentsOfAdditionPaidInCapitalAmortizationOfStockOptions`	$22.30K	USD	Annual
Purchase of Company stock	`StockIssuedDuringPeriodValueNewIssues`	$-10.80K	USD	Annual
Issuance of company stock for notes and other payables	`StockIssuedDuringPeriodValueOther`	$170.07K	USD	Annual
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$65.00K	USD	Annual
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$80.50K	USD	Annual
Issuance of stock options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$23.00K	USD	Annual
Company stock cancelled	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	Annual
Extension of option and warrant expiration dates	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationExtensionStockOptionsWarrantExpirationDates`	$22.00K	USD	Annual
Extension of option and warrant expiration dates	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationExtensionStockOptionsWarrantExpirationDates`	$55.00K	USD	Annual
Investment in subsidiary by noncontrolling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$178.15K	USD	Annual
Net (loss)	`ProfitLoss`	$-159.23K	USD	Annual
Net (loss)	`ProfitLoss`	$-460.49K	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$195.49K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-139.50K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.